Clinical Trials Browser

Phase 3 × Ferrosoferric Oxide × 90 days × Clear all

NCT07461948 2026-03-10

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Phase 3 Recruiting

Glioblastoma